Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats.

[1]  I. Szelenyi,et al.  5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug. , 1991, European journal of pharmacology.

[2]  R. Chess-Williams,et al.  5‐Hydroxytryptamine‐induced potentiation of cholinergic responses to electrical field stimulation in pig detrusor muscle , 2000, BJU international.

[3]  T. Blackburn,et al.  Further characterization of 5‐hydroxytryptamine receptors (putative 5‐HT2B) in rat stomach fundus longitudinal muscle , 1994, British journal of pharmacology.

[4]  Silvia Franchini,et al.  1,3‐Dioxolane‐Based Ligands as Rigid Analogues of Naftopidil: Structure–Affinity/Activity Relationships at α1 and 5‐HT1A Receptors , 2009, ChemMedChem.

[5]  D. Kim,et al.  Acute Effects of Serotonin on Rat Bladder Contractility , 2002, Urologia Internationalis.

[6]  M. Corsi,et al.  Pharmacological analysis of 5‐hydroxytryptamine effects on electrically stimulated human isolated urinary bladder , 1991, British journal of pharmacology.

[7]  K. Iizuka,et al.  Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta. , 1996, European journal of pharmacology.

[8]  T. Deguchi,et al.  Comparison of two α1‐adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study , 2006, BJU international.

[9]  T. Kitamura,et al.  Clinical efficacy of an α1A/D‐adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia , 2006 .

[10]  B. Roth,et al.  Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction: participation of Ca++ channels and phospholipase C. , 1985, The Journal of pharmacology and experimental therapeutics.

[11]  W. C. Groat.  Influence of central serotonergic mechanisms on lower urinary tract function , 2002 .

[12]  T. Lebret,et al.  Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscle , 2005, World Journal of Urology.

[13]  C. D. Richardson,et al.  Alpha1-adrenergic receptor subtypes in human detrusor. , 1998, The Journal of urology.

[14]  S. Palea,et al.  5-Hydroxytryptamine potentiates neurogenic contractions of rat isolated urinary bladder through both 5-HT(7) and 5-HT(2C) receptors. , 2011, European journal of pharmacology.

[15]  M. Kodama,et al.  Influence of 5‐hydroxytryptamine and the effect of a new serotonin receptor antagonist (sarpogrelate) on detrusor smooth muscle of streptozotocin‐induced diabetes mellitus in the rat * , 2000, International journal of urology : official journal of the Japanese Urological Association.

[16]  M. Tonini,et al.  Characterization of Prejunctional Serotonin Receptors Modulating [3H]Acetylcholine Release in the Human Detrusor , 2006, Journal of Pharmacology and Experimental Therapeutics.

[17]  P. H. van der Graaf,et al.  Characterisation of the 5-HT receptor potentiating neurotransmission in rabbit bladder. , 1996, European journal of pharmacology.

[18]  M. Breidert,et al.  Naftopidil inhibits 5-hydroxytryptamine-induced platelet aggregation and 5-hydroxytryptamine uptake in platelets of healthy volunteers , 2004, European Journal of Clinical Pharmacology.

[19]  T. Miki,et al.  Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: A prospective randomized controlled study , 2008, International journal of urology : official journal of the Japanese Urological Association.

[20]  P. Klarskov,et al.  Influence of serotonin on lower urinary tract smooth muscle in vitro. , 1986, British journal of urology.

[21]  G. Tsujimoto,et al.  FUNCTION OF THE LOWER URINARY TRACT IN MICE LACKING α1d-ADRENOCEPTOR , 2005 .

[22]  R. Morgan,et al.  Time-dependent up-regulation of neuronal 5-hydroxytryptamine binding sites in the detrusor of a rabbit model of partial bladder outlet obstruction , 1999, World Journal of Urology.

[23]  A. Ramage.  The role of central 5‐hydroxytryptamine (5‐HT, serotonin) receptors in the control of micturition , 2006, British journal of pharmacology.

[24]  R. Borman,et al.  Functional evidence for a 5‐HT2B receptor mediating contraction of longitudinal muscle in human small intestine , 1995, British journal of pharmacology.